Xcout IntelFerrosa Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Ferrosa Therapeutics among biotechnology companies — ranked by similarity to what Ferrosa Therapeutics actually does, not by market-cap band.
Subscribe to see Ferrosa Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Ferrosa Therapeutics
Ferrosa Therapeutics AG is a Swiss biotechnology company founded in Basel, Switzerland, focusing on developing novel therapeutics to treat anemia and related conditions.
Ferrosa Therapeutics at a glance
Ferrosa Therapeutics is a biotechnology company headquartered in Switzerland. Its most recent funding round, Seed, raised $3.5M in April 2026. Xcout tracks 3 named people at Ferrosa Therapeutics, including Martin Stern (CEO & Co-Founder · Board Member).
Ferrosa Therapeutics leadership
- Martin SternCEO & Co-Founder · Board Member
- Sara Núñez-GarcíaBoard Member & Co-Founder
- Sascha Oliver BucherBoard Member & Co-Founder
Ferrosa Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Seed | $3.5M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Ferrosa Therapeutics competitors
Ranked by semantic similarity — how close each company is to Ferrosa Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Sidero Bioscience is a clinical-stage biotechnology company that develops natural iron supplement products to address iron deficiency and nutritional health. Its proprietary SideroSorb platform and BioFe iron complex utilize a unique uptake mechanism designed to improve absorption and minimize gastrointestinal side effects compared to traditional iron therapies.
Similar biotechnology company
Vaderis Therapeutics AG is a clinical-stage biotechnology company focused on developing novel treatments for severe vascular diseases. The company is headquartered in Basel, Switzerland.
Biotech
Scarlet Therapeutics, founded in 2021 and headquartered in Bristol, United Kingdom, is developing a pioneering platform that generates novel red blood cell-based therapeutics to treat a wide range of diseases.
Biotech
Amporin Pharmaceuticals AG is a Swiss biotechnology company founded in Basel in 2024. The firm focuses on developing a new class of small-molecule drugs designed to target toxic membrane mechanisms.
Similar biotechnology company
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
Similar biotechnology company
Mosanna Therapeutics is a biopharmaceutical company with offices in Redwood City, California and Basel, Switzerland. The company focuses on developing novel treatments for metabolic and cardiovascular diseases. It launched with $80 million in funding to advance its clinical pipeline.
Similar biotechnology company
Mysthera Therapeutics AG is a biotechnology company headquartered in Basel, Switzerland, focused on developing first-in-class, oral therapeutics to treat inflammation-driven and related diseases.
Biotech
Keros Therapeutics is a clinical-stage biopharmaceutical company that develops novel therapeutics targeting the transforming growth factor-beta (TGF-ß) superfamily of proteins. The company focuses on creating treatments for patients with hematological and neuromuscular disorders linked to dysfunctional protein signaling.
Biotech
Granite Bio is a biotechnology company headquartered in Basel, Switzerland. It is developing first-in-class therapies by targeting fundamentals of biology and debuted with $100 million of capital.
Life Sciences
Rejuveron Life Sciences AG is a biotechnology company headquartered in Schlieren, Switzerland, focused on developing innovative therapeutics and therapies for aging-related diseases and longevity.
Biotech
TECregen AG is a biotechnology company headquartered in Basel, Switzerland. The company is dedicated to advancing immuno-rejuvenation through the development of next-generation therapies designed to regenerate the thymus.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Ferrosa Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Ferrosa Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →